The debate on Lucentis and Avastin

For those 200,000 AMD patients within an average year in US, the most effective treatment that approved by FDA is Lucentis. It brings hope to wet AMD patients by stopping and sometimes reversing vision loss, which is a huge breakthrough. Yet another drug that is similar to Lucentis is also under wide discussion, which is named Avastin. But Avastin is much cheaper than Lucentis, so that many doctors recommend Avastin for low-income individuals.